Clinical trials
Completed trials in Rwanda
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
115 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2005 | 5 |
| 2006 | 2 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 4 |
| 2011 | 7 |
| 2012 | 6 |
| 2013 | 10 |
| 2014 | 8 |
| 2015 | 3 |
| 2016 | 6 |
| 2017 | 8 |
| 2018 | 7 |
| 2019 | 3 |
| 2020 | 10 |
| 2021 | 13 |
| 2022 | 7 |
| 2023 | 5 |
| 2024 | 5 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 115 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ministry of Health, Rwanda | 7 |
| Brigham and Women's Hospital | 5 |
| University of Rwanda | 5 |
| Boston College | 4 |
| International AIDS Vaccine Initiative | 4 |
| Janssen Vaccines & Prevention B.V. | 4 |
| London School of Hygiene and Tropical Medicine | 4 |
| Novartis Pharmaceuticals | 4 |
| University Ghent | 4 |
| Foundation for Innovative New Diagnostics, Switzerland | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Acquired Immunodeficiency Syndrome | 13 |
| HIV Infections | 12 |
| Malaria | 11 |
| Malaria, Falciparum | 5 |
| Anxiety Disorders | 4 |
| Stress Disorders, Post-Traumatic | 4 |
| Breast Neoplasms | 2 |
| COVID-19 | 2 |
| Candidiasis, Vulvovaginal | 2 |
| Cystic Fibrosis | 2 |
Trials
Showing 26 to 50 of 115. Each trial links to its page on Pharma Observatory.
15 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.